Abstract: Human anti-human folate receptor beta antibodies and antigen-binding fragments thereof are described, as well as methods of using such antibodies and fragments to treat inflammatory disorders or cancers expressing cell surface FR?.
Type:
Grant
Filed:
October 27, 2014
Date of Patent:
March 13, 2018
Assignees:
PURDUE RESEARCH FOUNDATION, THE UNITED STATES OF AMERICA DEPEARTMENT OF HEALTH AND HUMAN SERVICES
Inventors:
Philip S. Low, Dimiter S. Dimitrov, Yang Feng, Jiayin Shen